Skip to content
ppharmaranks
Menu

Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor drugs compared

Compare all 3 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor drugs side by side, used for conditions such as chickenpox, herpes genitalis, herpes labialis. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is acyclovir sodium.

Top-rated herpes simplex virus nucleoside analog dna polymerase inhibitor: 1. Acyclovir Sodium · 2. Valtrex · 3. Acyclovir

Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor drugs compared side by side, with pharmaranks' FDA recall-safety rating
DrugGenericSafety ratingFDA recall-based
Acyclovir Sodium70/100
ValtrexValacyclovir Hydrochloride70/100
Acyclovir56/100

The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.

Full ranking · 3 drugs

  1. 1

    acyclovir sodium

    Acyclovir Sodium

    70/100
  2. 2

    valtrex

    Valacyclovir Hydrochloride

    70/100
  3. 3

    acyclovir

    Acyclovir

    56/100

Frequently asked questions

What is the Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor drug class?

Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 3 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor products, each independently rated.

Are all Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor drugs the same?

No. Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.

What conditions do Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor drugs treat?

Per NIH RxClass drug-classification data, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor drugs are used for conditions including chickenpox, herpes genitalis, herpes labialis, herpes zoster ophthalmicus, aids-related opportunistic infections, epstein-barr virus infections.

Which Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor drug is best-rated?

By our independent rating, acyclovir sodium currently ranks highest among Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.

Sources: the Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.